Intellia Therapeutics Gains FDA Priority Review for Lonvo-z in HAE
CAMBRIDGE, Mass. — September 8, 2026 Intellia Therapeutics announced that the U.S. Food and Drug Administration (FDA) has accepted...
gene editing
Advertisement
Sernova and Seraxis Merge to Create BetaNova Biotherapeutics
TORONTO, Canada and GERMANTOWN, Maryland — September 8, 2026 Sernova Biotherapeutics Inc. and Seraxis Holdings, Inc. announced a definitive...
Alcon Launches UNITY M Ophthalmic Microscope for Enhanced Surgical Precision
Geneva, Switzerland — September 2026 Alcon announced the commercial launch of UNITY® M, a premium ophthalmic surgical microscope designed...
eGenesis Reports Kidney Xenotransplantation Clinical Progress
Cambridge, Massachusetts — September 3, 2026 eGenesis announced an important clinical update from its ongoing Expanded Access study of...
CRISPR Therapeutics Reports Durable CTX310 Lipid Lowering
Zug, Switzerland & Boston, Mass. – August 28, 2026 CRISPR Therapeutics presented new Phase 1a durability data for CTX310,...
Advertisements
iECURE Reports 74% Reduction in OTC-HOPE Crises
Philadelphia – August 27, 2026 iECURE, Inc. presented updated clinical data from the ongoing OTC-HOPE Phase 1/2 trial of...
iECURE to Present ECUR-506 Clinical Data in OTC Deficiency
Philadelphia, August 20, 2026 iECURE announced that updated clinical data from the ongoing OTC-HOPE trial of ECUR-506 in infants...
Dassault Systèmes Powers Virtual Twin Factories with AI Agents
VELIZY-VILLACOUBLAY, France, July 23, 2026 Dassault Systèmes has expanded its 3DEXPERIENCE AI-native agentic platform with the launch of three...
Apertura Joins ARPA-H Program for Rare Gene Therapies
NEW YORK, N.Y., July 23, 2026 Apertura Gene Therapy has announced its participation in a consortium selected to receive...
Prime Medicine Achieves FDA Milestone for PM577a
CAMBRIDGE, Mass., July 23, 2026 Prime Medicine (Nasdaq: PRME) announced that the U.S. Food and Drug Administration (FDA) has...
Advertisement
